Search

everythinglearnresearchcommunity

for

Search:↓

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Using urinary bladder matrix and platelet rich plasma can effectively treat transplant scars and prevent hair loss.

RF-mesotherapy with bicalutamide may be a promising new treatment for hair loss.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Finasteride may reduce prostate bleeding by lowering blood vessel growth factor levels and blood vessel density in certain prostate areas.

Lower TNF-α levels in PRP may predict better treatment outcomes for bladder conditions.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Genetic variations may affect how well finasteride works for BPH patients.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Long-pulsed ruby laser effectively reduces hair in male-to-female transsexuals.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Sapium rotundifolium extract may help treat enlarged prostate.

Post-finasteride Syndrome causes lasting negative effects, but more research is needed for treatment and risk evaluation.

Finasteride causes temporary cell death in BPH tissues.